SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥145.53+CN¥2.64 (+1.85%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 16.17% below the high.
Loading market information…
OTC · LDDD · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Longduoduo Company Limited’s quoted price sits in the lower half of its reported 52-week range, 45.4% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Longduoduo Company Limited, along with its associated entities, operates within the People's Republic of China, focusing on providing proactive health management and preventative medical services. The company's comprehensive suite of offerings includes health screenings, diverse treatment options, and specialized healthcare products, all aimed at reducing the likelihood of severe conditions such as myocardial infarction (heart attacks), cerebral infarction (strokes), hemiplegia (paralysis), and other cardiovascular and cerebrovascular diseases. These services are delivered through an extensive network of external collaborators, including independent healthcare providers, product vendors, and sales representatives. Additionally, Longduoduo features a range of advanced therapeutic interventions. These encompass meridian-regulating and consciousness-restoring techniques, a double blood purification process, immunological ozonated autohemotherapy, platelet-rich plasma therapy, relaxation techniques, vegetative nerve regulation, and microwave therapy. Established in 2020, the firm's primary operational base is located in Hohhot, China.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:55 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥145.53+CN¥2.64 (+1.85%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 16.17% below the high.
CN¥49.03+CN¥0.41 (+0.84%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.52% below the high.
$2.02$0.00 (0.0%)
Zhong Yuan Bio-Technology Holdings Limited: Healthcare · Medical - Distribution.
$0.65+$0.03 (+4.84%)
China Pharma Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.61% below the high.
$2.98+$0.01 (+0.34%)
111, Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.32% below the high.
$0.32$0.00 (0.0%)
Kun Peng International Ltd’s quoted price sits in the lower half of its reported 52-week range, 57.22% below the high.
$1.54-$0.39 (-20.21%)
Universe Pharmaceuticals Inc.’s quoted price sits in the lower half of its reported 52-week range, 91.43% below the high.
$0.02-$0.00 (-8.26%)
China Medicine Corp.’s quoted price sits in the lower half of its reported 52-week range, 69.33% below the high.
